Completed NA INTERVENTIONAL 2-arm NCT03325335

Assessing the Effectiveness of Midazolam Premedication

Randomized Controlled Trial Assessing the Effectiveness of Midazolam Premedication as an Anxiolytic, Analgesic, Sedative, and Hemodynamic Stabilizer

Sponsor: Pusan National University Hospital

Conditions Anxiety Preoperative Midazolam Premedication Premedication

Interventions Midazolam premedication Propofol infusion Remifentanil infusion

Updated 6 times since 2017 Last updated: Oct 28, 2017 Started: Jul 19, 2016 Primary completion: Aug 14, 2017 Completion: Aug 15, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anxiety Preoperative and Midazolam Premedication and is currently completed. Pusan National University Hospital leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Nov 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pusan National University Hospital

Data source: Pusan National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Busan, South Korea